IMPORTANCE OF GENETIC-FACTORS IN THE REGULATION OF DIAZEPAM METABOLISM - RELATIONSHIP TO S-MEPHENYTOIN, BUT NOT DEBRISOQUIN, HYDROXYLATION PHENOTYPE

被引：263
作者：
BERTILSSON, L
HENTHORN, TK
SANZ, E
TYBRING, G
SAWE, J
VILLEN, T
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1989年 / 45卷 / 04期
关键词：
D O I：
10.1038/clpt.1989.40
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：348 / 355
页数：8
相关论文
共 41 条
[1]  
ABERNETHY DR, 1983, J PHARMACOL EXP THER, V224, P508
[2]   PHARMACOGENETIC STUDY WITH DIAZEPAM IN TWINS [J].
ALDA, M ;
DVORAKOVA, M ;
POSMUROVA, M ;
BALIKOVA, M ;
ZVOLSKY, P ;
FILIP, V .
NEUROPSYCHOBIOLOGY, 1987, 17 (1-2) :4-8
[3]  
BERLIN A, 1972, CLIN PHARMACOL THER, V13, P733
[4]   PHARMACOKINETICS AND METABOLISM OF VARIOUS BENZODIAZEPINES USED AS HYPNOTICS [J].
BREIMER, DD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 :S7-S13
[5]   PHARMACOKINETICS OF CLOSELY RELATED BENZODIAZEPINES [J].
CURRY, SH ;
WHELPTON, R .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 :S15-S21
[6]   EFFECTS AND PLASMA-LEVELS OF N-DESMETHYLDIAZEPAM AFTER ORAL-ADMINISTRATION IN NORMAL VOLUNTEERS [J].
DASBERG, HH .
PSYCHOPHARMACOLOGIA, 1975, 43 (02) :191-198
[7]  
DUTCHER JS, 1977, CLIN PHARMACOL THER, V22, P447
[8]   POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES [J].
EICHELBAUM, M ;
BERTILSSON, L ;
SAWE, J ;
ZEKORN, C .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) :184-186
[9]  
EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001
[10]   A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION [J].
EVANS, DAP ;
MAHGOUB, A ;
SLOAN, TP ;
IDLE, JR ;
SMITH, RL .
JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) :102-105
12345